Related Experiment Videos
Clonal light chain restricted primary intrapulmonary nodular amyloidosis.
Patrick Ross1, Cynthia M Magro
1Division of Cardiothoracic Surgery, The Ohio State University, Columbus, Ohio 43210, USA. ross-3@medctr.osu.edu
The Annals of Thoracic Surgery
|June 25, 2005
Summary
Primary intrapulmonary nodular amyloidosis, a rare lung condition, may stem from a light chain restricted clonal lymphocytic infiltrate. This finding suggests some cases could be a low-grade B-cell lymphoproliferative disease, not just chronic inflammation.
Area of Science:
- Pulmonary Pathology
- Immunopathology
- Hematology
Background:
- Primary intrapulmonary nodular amyloidosis (PINA) is a rare immunoglobulin-associated condition, often termed amyloidoma.
- Historically, pulmonary amyloidomas were presumed to arise from chronic inflammation.
- Amyloidomas at other sites can indicate plasma cell dyscrasias, but the lung origin was less clear.
Observation:
- Two patients with PINA were analyzed.
- Pathologic examination revealed a light chain-restricted clonal lymphocytic plasma cell infiltrate in both cases.
- Crucially, no morphologic features of coexisting pulmonary lymphoma were identified.
Findings:
- The underlying pathology of these PINA cases was a clonal lymphocytic infiltrate.
- This infiltrate was restricted by light chain expression, indicating a neoplastic process.
- The absence of overt lymphoma features differentiates these cases.
Implications:
- These findings challenge the traditional view of PINA solely as a reactive inflammatory process.
- They suggest that some PINA cases represent a distinct manifestation of low-grade B-cell lymphoproliferative disease.
- This reclassification has potential diagnostic and therapeutic implications for patients with PINA.